Wednesday, July 8, 2026

pharma · Fertility · INTI

Inhibitor Therapeutics

INHIBITOR Therapeutics is a pharma organization headquartered in Tampa, USA. It trades on NYSE under ticker INTI. Primary therapeutic focus areas include Fertility. NovaPharmaNews links 2 clinical program(s), 0 drug prof

Tampa, USA HQ
2013 Founded
5 Employees
Public company Type
INTI · NYSE Ticker
Company details
Status
Public
HQ
Tampa, USA
Founded
2013
Employees
5
Programs
2
Drugs
2
Patents
5
Clinical program

Window of Implantation

Unknown · other · IVF

Window of Implantation for IVF is a Unknown program (other) at Inhibitor Therapeutics with 1 ClinicalTrials.gov record(s).

Internal code IntiLabs

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Inhibitor Therapeutics
Phase
Unknown
Modality
other
Indication
IVF
Status
active
Trials
1